BMS awarded 2018 ENERGY STAR Partner of the Year Sustained Excellence Award

3 Apr 2018

The company’s environmental efforts honored for the fourth consecutive year.

The US Environmental Protection Agency (EPA) and the US Department of Energy have recognized Bristol-Myers Squibb (BMS) with an ENERGY STAR Partner of the Year Sustained Excellence Award for outstanding efforts to improve the energy efficiency of facilities worldwide. BMS has earned the ENERGY STAR Partner of the Year award for the past 4 consecutive years.

BMS awarded 2018 ENERGY STAR Partner of the Year Sustained Excellence Award

The award confirms BMS’s long-term commitment to environmental responsibility through driving sustainable improvements in energy with a goal of reducing the company use or resources across its drug discovery, development and delivery pipeline.

“We are proud to receive the ENERGY STAR Partner of the Year designation for 4 years, and to increase our recognition with the Sustained Excellence Award,” said Carol Ryerkerk Powell, vice president of Environment, Health, Safety and Sustainability, BMS. “To continue developing innovative medicines for our patients, we have to embrace our responsibility to support our environment, employees and communities. We look forward to our continued partnership with ENERGY STAR to better advance our energy management programs and demonstrate our leadership within the pharmaceutical industry.”

BMS was recognized for the following accomplishments:
  • Achieving an annual energy intensity improvement of more than $% globally, contributing to an 11.3% reduction in energy consumption since 2013.
  • Assisting the ENERGY STAR program with energy treasure hunt training for healthcare energy managers and conducting a treasure hunt with an external organization, St Joseph’s Medical Center in Bloomington, Illinois.
  • Achieving the ENERGY STAR Challenge for Industry at two sites and taking the challenge at eight new sites.
  • Hosting the first ENERGY STAR showcase event at a pharmaceutical facility that engaged employees, local government officials and ENERGY STAR industrial partners.
  • Earning ENERGY STAR certification at two office buildings.
  • Actively participating in the ENERGY STAR Focus on Energy Efficiency in Pharmaceutical Manufacturing and the ENERGY STAR industrial partnership.
  • Investing over $42.4 million across 342 energy projects to achieve an annualized savings of over $18.3 million since 2010.
  • In addition to the company’s recognition as an ENERGY STAR Partner of the Year, BMS’s R&D site in Hopewell, New Jersey, and the manufacturing site in New Brunswick, New Jersey earned the 2017 Challenge for Industry recognition. The ENERGY STAR Challenge for Industry is a national call-to-action to improve energy efficiency of America’s manufacturers by 10% or more. By taking the ENERGY STAR Challenge, sites set a goal to reduce their energy intensity by 10% within 5 years.

    Read More

    Related tags

    Market News

    Related news

    Specialist API CDMO acquired by GHO Capital

    Specialist API CDMO acquired by GHO Capital

    16 Mar 2019

    Future plan is to extend Sterling’s international presence to meet increasing demand from customers worldwide.

    Read more 
    Bringing next generation single-use sensor technologies to the life science market

    Bringing next generation single-use sensor technologies to the life science market

    14 Mar 2019

    Pall and Broadley-James’ combined expertise proves complementary in addressing critical customer pain points in modern bioprocessing.

    Read more 
    Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

    Third Sartorius Research Xchange Forum 2019 focuses on CAR-T cell therapy

    13 Mar 2019

    Event for experts from academia and industry, including talks, live demo sessions, and panel discussion.

    Read more 
    TraceLink submits an interoperable blockchain network solution for FDA DSCSA Pilot Project Program

    TraceLink submits an interoperable blockchain network solution for FDA DSCSA Pilot Project Program

    12 Mar 2019

    Trace Histories is a purpose-built distributed ledger solution for ensuring patient safety by 2023 DSCSA deadline.

    Read more 
    Overcoming lyophilization challenges at Interphex 2019

    Overcoming lyophilization challenges at Interphex 2019

    10 Mar 2019

    Line of Sight approach to freeze-drying enables organizations to bring pharmaceutical products safely and quickly to market.

    Read more 
    Catalent invests over $27 million to commercialize Zydis Ultra

    Catalent invests over $27 million to commercialize Zydis Ultra

    7 Mar 2019

    Zydis Ultra allows a patented and innovative drug coating to be introduced during a product’s formulation, enabling the dosage of active ingredient to be up to four times higher than a conventional Zydis ODT.

    Read more 
    Novel systems for membrane chromatography

    Novel systems for membrane chromatography

    6 Mar 2019

    Optimally run membrane chromatography processes will provide higher productivity, smaller-scale operations and increased robustness.

    Read more 
    Lilly to introduce lower-priced insulin

    Lilly to introduce lower-priced insulin

    5 Mar 2019

    Authorized generic version of Humalog will be available in US pharmacies at 50% lower list price.

    Read more 
    Biogen acquisition boosts its ophthalmology pipeline

    Biogen acquisition boosts its ophthalmology pipeline

    4 Mar 2019

    Nightstar Therapeutics has two potentially first-in-class mid- to late-stage clinical assets as well as preclinical programs.

    Read more 
    Uniqsis expands LED photoreactor range

    Uniqsis expands LED photoreactor range

    3 Mar 2019

    The availability of three new alternative switchable LED configurations provides chemists with the unique ability to optimally undertake almost any photochemistry reaction.

    Read more